v3.25.4
Transfer of Financial Assets, Assets Pledged and Received as Collateral
12 Months Ended
Dec. 31, 2025
Transfers of Financial Assets [Abstract]  
Transfer of Financial Assets, Assets Pledged and Received as Collateral 20 — Transfer of Financial Assets, Assets Pledged and Received
as Collateral
The Group enters into transactions in which it transfers financial assets held on the balance sheet and as a result may
either be eligible to derecognize the transferred asset in its entirety or must continue to recognize the transferred asset
to the extent of any continuing involvement, depending on certain criteria. These criteria are discussed in Note 01
“Material Accounting Policies and Critical Accounting Estimates”.
Where financial assets are not eligible to be derecognized, the transfers are viewed as secured financing transactions,
with any consideration received resulting in a corresponding liability. The Group is not entitled to use these financial
assets for any other purposes. The most common transactions of this nature entered into by the Group are repurchase
agreements, securities lending agreements and total return swaps, in which the Group retains substantially all of the
associated credit, equity price, interest rate and foreign exchange risks and rewards associated with the assets as well as
the associated income streams.
Information on asset types and associated transactions that did not qualify for derecognition
in € m.
Dec 31, 2025
Dec 31, 2024
Carrying amount of transferred assets
Trading securities not derecognized due to the following transactions:
Repurchase agreements
46,744
40,438
Securities lending agreements
10,344
8,313
Total return swaps
20,248
14,013
Other
1,503
2,523
Total trading securities
78,839
65,288
Other trading assets
40
51
Non-trading financial assets mandatory at fair value through profit or loss
32
107
Financial assets at fair value through other comprehensive income
11,198
5,134
Loans at amortized cost1
15
17
Others
11,568
4,335
Total
101,693
74,931
Carrying amount of associated liabilities
91,380
66,654
¹Other traded loans where the associated liability is recourse only to the transferred assets had carrying value and fair value of € 0 million and € 0 million as at December
31, 2025, and December 31, 2024 respectively. The associated liabilities had the same carrying value and fair value which resulted in a net position of € 0 million and € 0
million as at December 31, 2025 and December 31, 2024 respectively
Carrying value of assets transferred to the Group has continuing involvement
in € m.
Dec 31, 2025
Dec 31, 2024
Carrying amount of the original assets transferred
Trading securities
1,016
1,073
Non-trading financial assets mandatory at fair value through profit or loss
—
—
Carrying amount of the assets continued to be recognized
Trading securities
21
26
Non-trading financial assets mandatory at fair value through profit or loss
—
—
Carrying amount of associated liabilities
40
52
The Group could retain some exposure to the future performance of a transferred asset either through new or existing
contractual rights and obligations and still be eligible to derecognize the asset. This ongoing involvement will be
recognized as a new instrument which may be different from the original financial asset that was transferred. Typical
transactions include retaining senior notes of non-consolidated securitizations to which originated loans have been
transferred; financing arrangements with structured entities to which the Group has sold a portfolio of assets; or sales of
assets with credit-contingent swaps. The Group’s exposure to such transactions is not considered to be significant as any
substantial retention of risks associated with the transferred asset will commonly result in an initial failure to
derecognize. Transactions not considered to result in an ongoing involvement include normal warranties on fraudulent
activities that could invalidate a transfer in the event of legal action, qualifying pass-through arrangements and standard
trustee or administrative fees that are not linked to performance.
The impact on the Group’s Balance Sheet of on-going involvement associated with transferred assets derecognized in full
Dec 31, 2025
Dec 31, 2024
in € m.
Carrying
value
Fair value
Maximum
Exposure
to Loss¹
Carrying
value
Fair value
Maximum
Exposure
to Loss¹
Loans at amortized cost
Securitization notes
479
459
459
441
397
397
Other
—
—
—
—
—
—
Total loans at amortized cost
479
459
459
441
397
397
Financial assets held at fair value through
profit or loss
Securitization notes
—
—
—
—
—
—
Non-standard Interest Rate, cross-
currency or inflation-linked swap
—
—
—
—
—
—
Total financial assets held at fair value
through profit or loss
—
—
—
—
—
—
Financial assets at fair value through
other comprehensive income:
Securitization notes
532
466
466
669
560
560
Other
—
—
—
—
—
—
Total financial assets at fair value through
other comprehensive income
532
466
466
669
560
560
Total financial assets representing on-
going involvement
1,011
925
925
1,110
957
957
Financial liabilities held at fair value
through profit or loss
Non-standard Interest Rate, cross-
currency or inflation-linked swap
—
—
—
—
—
—
Total financial liabilities representing on-
going involvement
—
—
—
—
—
—
1The maximum exposure to loss is defined as the carrying value plus the notional value of any undrawn loan commitments not recognized as liabilities
The impact on the Group’s Statement of Income of on-going involvement associated with transferred assets derecognized in full
Dec 31, 2025
Dec 31, 2024
in € m.
Year-to-date
P&L
Cumulative P&L
Gain/(loss) on
disposal
Year-to-date
P&L
Cumulative P&L
Gain/(loss) on
disposal
Securitization notes
38
239
23
50
220
25
Non-standard Interest Rate, cross-
currency or inflation-linked swap
—
—
—
—
—
—
Net gains/(losses) recognized from on-
going
involvement in derecognized assets
38
239
23
50
220
25
The Group pledges assets primarily as collateral against secured funding and for repurchase agreements, securities
borrowing agreements as well as other borrowing arrangements and for margining purposes on OTC derivative liabilities.
Pledges are generally conducted under terms that are usual and customary for standard securitized borrowing contracts
and other transactions described. As at December 31, 2025 the bank had securitized loans of € 7 billion and the secured
own bonds were pledged as collateral into various market standard securities financing transactions. The encumbered
loans below include these balances.
Carrying value of the Group’s assets pledged as collateral for liabilities or contingent liabilities1
in € m.
Dec 31, 2025
Dec 31, 2024
Financial assets at fair value through profit or loss
70,166
58,749
Financial assets at fair value through other comprehensive income
11,329
5,263
Loans
37,996
41,758
Other
12,216
4,462
Total
131,708
110,232
1Excludes assets pledged as collateral from transactions that do not result in liabilities or contingent liabilities
Total assets pledged to creditors available for sale or repledge1
in € m.
Dec 31, 2025
Dec 31, 2024
Financial assets at fair value through profit or loss
67,159
55,310
Financial assets at fair value through other comprehensive income
11,084
5,013
Loans
3,063
4,618
Other
11,569
2,904
Total
92,875
67,845
1Includes assets pledged as collateral from transactions that do not result in liabilities or contingent liabilities
The Group receives collateral primarily in reverse repurchase agreements, securities lending agreements, derivatives
transactions, customer margin loans and other transactions. These transactions are generally conducted under terms
that are usual and customary for standard secured lending activities and the other transactions described. The Group, as
the secured party, has the right to sell or re-pledge such collateral, subject to the Group returning equivalent securities
upon completion of the transaction. This right is used primarily to cover short sales, securities loaned and securities sold
under repurchase agreements.
Fair Value of collateral received
in € m.
Dec 31, 2025
Dec 31, 2024
Securities and other financial assets accepted as collateral
557,837
479,022
Of which:
Collateral sold or repledged
431,792
366,245